1. Angiosarcoma of the scalp successfully treated with pazopanib
Hajime Tomita, MD, PhD, Yuta Koike, MD, PhD, Misachi Asai, MD, Fumihide Ogawa, MD, PhD, Kuniko Abe, MD, PhD, Miki Tanioka, MD, PhD, Atsushi Utani, MD, PhD 
Journal of the American Academy of Dermatology 
Volume 70, Issue 1, Pages e19-e21 (January 2014)
DOI: /j.jaad
Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Angiosarcoma treated with pazopanib. Improvements in edema and erythema and a reduction in the size of the left cheek indurated plaque are seen following pazopanib therapy. A, Before pazopanib therapy. B, Fourteen days after the commencement of pazopanib therapy.
Journal of the American Academy of Dermatology  , e19-e21DOI: ( /j.jaad )
Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
Angiosarcoma treated with pazopanib. Serial computed tomography scans. Scans show varying responses in multiple intraparotid lymph nodes (arrows). A, Before pazopanib therapy. B, Nineteen days after the commencement of pazopanib therapy.
Journal of the American Academy of Dermatology  , e19-e21DOI: ( /j.jaad )
Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions